Overview
Bloom syndrome (also known as Bloom-Torre-Machacek syndrome or congenital telangiectatic erythema) is a rare autosomal recessive genetic disorder caused by biallelic pathogenic variants in the BLM gene (also called RECQL3), which encodes a RecQ family DNA helicase essential for maintaining genomic stability. The hallmark of the condition is marked chromosomal instability, with greatly increased rates of sister chromatid exchanges, which underlies the dramatically elevated predisposition to a wide spectrum of cancers occurring at unusually young ages. Clinical features typically manifest in infancy and include severe pre- and postnatal growth restriction resulting in proportionate short stature, a sun-sensitive telangiectatic erythema predominantly affecting the face (especially the butterfly area of the cheeks and nose), a high-pitched voice, and a characteristic narrow, long facial appearance with a small mandible and prominent nose and ears. Affected individuals frequently experience immunodeficiency with recurrent infections, insulin resistance or diabetes mellitus, and male infertility due to absent spermatogenesis. Females may have reduced fertility but can reproduce. Mild to moderate intellectual ability is typical, though intelligence is usually normal. The most serious complication is a markedly increased risk of malignancy, including leukemias, lymphomas, and various solid tumors, often occurring in childhood or early adulthood. There is no specific curative treatment for Bloom syndrome. Management is supportive and includes strict sun protection, growth monitoring, nutritional support, surveillance for diabetes, aggressive treatment of infections, and rigorous cancer surveillance protocols. Chemotherapy and radiation doses may need to be reduced due to the underlying chromosomal fragility. The Bloom Syndrome Registry, maintained since 1960, has been instrumental in characterizing the natural history of this condition.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
1 eventData sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Bloom syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Bloom syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Bloom syndrome.
Community
No community posts yet. Be the first to share your experience with Bloom syndrome.
Start the conversation →Latest news about Bloom syndrome
Disease timeline:
New recruiting trial: BLOOM: Pragmatic Feasibility Trial
A new clinical trial is recruiting patients for Bloom syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Bloom syndrome
What is Bloom syndrome?
Bloom syndrome (also known as Bloom-Torre-Machacek syndrome or congenital telangiectatic erythema) is a rare autosomal recessive genetic disorder caused by biallelic pathogenic variants in the BLM gene (also called RECQL3), which encodes a RecQ family DNA helicase essential for maintaining genomic stability. The hallmark of the condition is marked chromosomal instability, with greatly increased rates of sister chromatid exchanges, which underlies the dramatically elevated predisposition to a wide spectrum of cancers occurring at unusually young ages. Clinical features typically manifest in in
How is Bloom syndrome inherited?
Bloom syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Bloom syndrome typically begin?
Typical onset of Bloom syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Bloom syndrome?
1 specialists and care centers treating Bloom syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.